Praxis Precisions Medicines Inc (PRAX)
Star Equity Holdings Inc. (STRRP)
Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13
Vor Biopharma Inc (VOR)
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
Praxis Precisions Medicines Inc (PRAX)
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Equillium Inc. (EQ)
Equillium - Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy
Cognex Corporation (CGNX)
Cognex Corporation - Cognex to Present at the KeyBanc Capital Markets Technology Leadership Forum
Heart Test Laboratories Inc (HSCSW)
Ocugen Inc. (OCGN)
Star Equity Holdings Inc. (STRR)
Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13
Rewalk Robotics Ltd (LFWD)
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
Hyperfine Inc (HYPR)
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-GenerationSwoop® System
Bioventus Inc (BVS)
New Form 8-K - Bioventus Inc. Filed: 2025-08-04 AccNo: 0001193125-25-172192 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
Mural Oncology (MURA)
908 Devices Inc (MASS)
New Form 8-K - 908 Devices Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073391 Size: 223 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits